Volume 19, Number 10—October 2013
Research
Plasmodium vivax Malaria during Pregnancy, Bolivia
Table 1
Baseline characteristics of women and babies at delivery during a hospital-based survey, Guayaramerín and Bermejo Bolivia, 2002–2004*
| Characteristic | Guayaramerín, n = 1,003 | Bermejo, n = 504 | p value |
|---|---|---|---|
| Mothers | |||
| Age, y | 23.2 ± 6.4 | 24.2 ± 6.7 | 0.008 |
| No. previous pregnancies | 2.1 ± 2.4 | 1.9 ± 2.1 | 0.40 |
| Primiparae | 31.7 | 28.4 | 0.18 |
| No. antenatal visits | 4.7 ± 2.0 | 3.7 ± 2.1 | <0.001 |
| No antenatal visit | 1.9 | 7.8 | <0.001 |
| Houses with indoor insecticide spraying | 55.0 | 50.3 | 0.098 |
| Women living in rural settlements | 6.8 | 22.7 | <0.001 |
| Delivery during transmission season | 60.0 | 52.6 | 0.006 |
| Hemoglobin level, g/dL | 11.1 ± 2.0 | 11.4 ± 1.9 | <0.001 |
| Moderate-to-severe anemia, hemoglobin level <8 g/dL | 6.8 | 6.3 | 0.70 |
| Babies | |||
| Girls | 47.5 | 49.8 | 0.41 |
| Birthweight, g | 3,310 ± 509 | 3,383 ± 515 | 0.003 |
| Low birthweight, <2,500 g | 5.0 | 4.8 | 0.83 |
| Premature babies, <37 weeks | 7.6 | 4.4 | 0.018 |
| Placental Plasmodium vivax infection | 2.7 | 3.0 | 0.73 |
| Placental P. falciparum infection | 0.4 | NA | NA |
*Values are mean ± SD or percentage. Significant values (p<0.05) are indicated in boldface. NA, not applicable.
Page created: August 14, 2013
Page updated: September 16, 2013
Page reviewed: September 16, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.